Navigation Links
MiMedx Group Announces Temporary Trading Symbol Designation

ATLANTA, Feb. 22 /PRNewswire-FirstCall/ -- MiMedx Group, Inc. (OTC Bulletin Board: MDXG) has received numerous inquiries regarding the temporary change of its symbol to "MDXGE.OB" rather than "MDXG.OB".  This resulted from the change of the Company's fiscal year to a calendar year, as reported on form 8-K filed December 21, 2009.  The matter has been resolved and the OTC:BB has advised the Company that its stock will resume trading under "MDXG.OB" on Tuesday, February 23. Until such time, as was the case today, the Company's shares may be traded using the temporary symbol.

About MiMedx Group, Inc.

MiMedx Group, Inc. is an integrated developer, manufacturer and marketer of patent protected biomaterial-based products and is in the process of transitioning from a development-focused concern to an operating company focused on sales growth and profitability. The Company's assets include intellectual property protecting a collagen-based technology for augmentation of soft and connective tissue diseases and trauma and intellectual property protecting a novel durable hydrogel technology. The Company has received FDA clearance for its first durable hydrogel product, the Paradis Vaso Shield ™ indicated for use as a cover for vessels following anterior spinal surgery.

Important Note regarding forward-looking statements and risk factors. This press release includes statements that look forward in time or that express management's beliefs, expectations or hopes. These statements include those regarding the date on which its shares will resume trading under its former symbol. These risks and uncertainties include that the resumption may be delayed due to administrative issues . The risks and uncertainties also include the risk factors detailed in its Securities and Exchange Commission filings, including, without limitation, its 10-K filing for the fiscal year ended March 31, 2009, and its most recent Form 10-Q filed on November 16, 2009. The Company does not undertake to update its forward-looking statements.

SOURCE MiMedx Group, Inc.

Back to top
SOURCE MiMedx Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. MiMedx Group, Inc. Adds Ronald G. Wallace to Board of Directors
2. MiMedx Group Announces Post-split Name Change
3. MiMedx Announces Brian J. Splan as President
4. Alynx, Co. Completes Merger With Medical Device Company MiMedx, Inc.
5. Anpath Group, Inc. Announces Fiscal 2010 Third Quarter Results
6. Encorium Group, Inc. Announces One-for-Eight Reverse Stock Split
7. Invida Selects LaVoie Group as Public Relations Agency of Record
8. Michael Langley, DVM, MBA, RAC Joins the Anson Group as a Regulatory Consultant
9. China YCT International Group, Inc. Announces That the State Intellectual Property Office of the Peoples Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd.
10. Danaher Completes Offer for Genetix Group plc
11. Lori Kahler Appointed President of The RC Insight Group
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015  Asia-Pacific (APAC) holds ... organisation (CRO) market. The trend of outsourcing to ... margins but higher volume share for the region ... scale, however, margins in the CRO industry will ... Market ( ), finds that the ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... be speaking at the following conference, and invited investors ... York, NY      Tuesday, December 1, 2015 at ... York, NY      Tuesday, December 1, 2015 at ... Healthcare Conference, New York, NY ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... of the year and one of the premier annual events for pharmaceutical manufacturing: ... from 8–11 November 2015, where ISPE hosted the largest number of attendees in ...
Breaking Biology Technology:
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
(Date:11/2/2015)... 2, 2015  SRI International has been awarded a ... development services to the National Cancer Institute (NCI) PREVENT ... scientific expertise, modern testing and support facilities, and analytical ... and toxicology studies to evaluate potential cancer prevention drugs. ... PREVENT Cancer Drug Development Program is an NCI-supported pipeline ...
Breaking Biology News(10 mins):